Alnylam Pharmaceuticals
ALNY
#1113
Rank
$21.40 B
Marketcap
$159.85
Share price
5.41%
Change (1 day)
-64.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company